Revenue from the core Skin Care business amounted to around DKK 400 million in FY 2023/24, with an operating profitability level significantly below the group EBIT margin. Coloplast’s FY 2024/25 ...

Coloplast A/S (OTCMKTS:CLPBF – Get Free Report) was the target of a large increase in short interest in the month of December ...

UBS also flagged recent structural changes, including Coloplast’s disposal of its skin care portfolio, which has led to minor revenue adjustments but no material impact on earnings estimates.